Contact Us
.
Ebook

Innovative Contracting for Medicines

How this phenomenon is evolving globally, and how AI can help with successful deployment.

Innovative contracting is moving from experimentation to a core operating model for managing high-cost, high-uncertainty medicines. In this eBook, independent contracting and payer experts explore how value-based agreements are evolving worldwide and how artificial intelligence (AI) can help manufacturers and payers design, negotiate, and operationalize these contracts more effectively.

Innovative Contracting for Medicines

Why read this eBook?

High-cost therapies, accelerated approvals, and increased budget scrutiny are reshaping how medicines are priced and reimbursed. Traditional volume-based pricing no longer works for many treatments, especially cell and gene therapies, rare disease drugs, and oncology products.

This eBook examines how innovative contracts, including value-based agreements, are becoming essential to aligning price with real-world outcomes and managing uncertainty at scale.

Key takeaways:
  • How innovative contracting has evolved globally and where it is most widely used
  • The different types of value-based agreements and when each model makes sense
  • Key barriers that prevent wider adoption of innovative contracts
  • How AI supports contract design, modeling, negotiation, and execution
  • Practical ways AI can improve outcomes tracking, rebate management, and pricing agility

Download the eBook

About the eBook

This eBook presents an independent perspective developed by an experienced consultant in collaboration with current and former payers across multiple international markets. All insights are anonymized and grounded in primary and secondary research.